Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Debt / NOTE 1.500% 4/1
-
Market price (% of par)
-
65.75%
-
Total 13F principal
-
$218,899,500
-
Principal change
-
-$2,507,000
-
Total reported market value
-
$145,364,935
-
Number of holders
-
29
-
Value change
-
-$2,270,074
-
Number of buys
-
8
-
Number of sells
-
8
Institutional Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q4 2022
As of 31 Dec 2022,
COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 was held by
29 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$218,899,500
in principal (par value) of the bond.
The largest 10 bondholders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, UBS ASSET MANAGEMENT AMERICAS INC, COURAGE CAPITAL MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, WOLVERINE ASSET MANAGEMENT LLC, AQR Arbitrage LLC, D. E. Shaw & Co., Inc., Calamos Advisors LLC, and GABELLI FUNDS LLC.
This page lists
29
institutional bondholders reporting positions
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.